Preventing Chronic Disease (PCD) is a peer-reviewed electronic journal established by the National Center for Chronic Disease Prevention and Health Promotion. PCD provides an open exchange of information and knowledge among researchers, practitioners, policy makers, and others who strive to improve the health of the public through chronic disease prevention.
Tea is a steeped beverage made from the leaves of Camellia sinensis. Globally, this healthy, caffeine-containing drink is one of the most widely consumed beverages. At least 50 countries produce tea and most of the production information and tea research is derived from international sources. Here, we discuss information related to tea production, genetics, and chemistry as well as production issues that affect or are likely to affect emerging tea production in the USA. With this review, we relay current knowledge on tea production, threats to tea production, and solutions to production problems to inform this emerging market in the USA.
Drive To Succeed gsu.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gsu.edu Daily Mail and Mail on Sunday newspapers.
Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates sciencemag.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencemag.org Daily Mail and Mail on Sunday newspapers.
Subscribe
New research led by Nita A. Limdi at the University of Alabama at Birmingham reports that the presence of chronic kidney disease is a major factor affecting the efficacy and safety of anticoagulant medications taken to prevent blood clots. The findings, reported in Clinical Pharmacology and Therapeutics, shine a spotlight on the effects of chronic kidney disease on the outcomes of patients taking traditional anticoagulants or newer direct-acting oral anticoagulants.
Patients with cardiovascular disease are frequently prescribed anticoagulants to prevent blood clots from forming and potentially leading to stroke or systemic embolism. The new study looked at traditional anticoagulants such as warfarin, and a newer class of direct-acting anticoagulants, such as apixaban, dabigatran and others.